Reproducible Molecular Subtypes in Systemic Lupus Erythematosus Are Associated With Disease Activity, Serology, and Distinct Trajectories Over Time - Scorecard - MDSpire

Consistent Molecular Subtypes in Systemic Lupus Erythematosus Correlate With Disease Activity, Serological Profiles, and Unique Longitudinal Patterns

  • By

  • Loqmane Seridi

  • Eugene Myshkin

  • Erika Noss

  • Sheng Gao

  • Julio Molineros

  • Carolyn Cuff

  • Dawn Waterworth

  • Matthew J. Loza

  • July 1, 2026

Share

Clinical Scorecard: Consistent Molecular Subtypes in Systemic Lupus Erythematosus Correlate With Disease Activity, Serological Profiles, and Unique Longitudinal Patterns

At a Glance

CategoryDetail
ConditionSystemic Lupus Erythematosus
Key MechanismsMolecular stratification, interferon signaling, B cell/plasmablast activation
Target PopulationPatients with active SLE (SLEDAI ≥ 6)
Care SettingClinical trials and observational studies

Key Highlights

  • Identification of robust molecular subtypes in SLE using large cohorts
  • Correlation of IFN signatures with disease activity and renal involvement
  • B cell/plasmablast programs associated with serologic activity
  • Use of serum proteomics to capture inflammatory pathways
  • Need for larger multicohort studies to validate findings

Guideline-Based Recommendations

Diagnosis

  • Utilize SLEDAI score for screening and assessing disease activity

Management

  • Consider B cell-targeted therapies such as rituximab for treatment

Monitoring & Follow-up

  • Assess molecular subtypes and serological profiles for disease activity

Risks

  • Potential for heterogeneous manifestations complicating treatment selection

Patient & Prescribing Data

Patients aged 16 to 75 years with active SLE

Ustekinumab evaluated in phase 2 and phase 3 trials

Clinical Best Practices

  • Leverage whole-blood transcriptomic studies for patient subtyping
  • Incorporate serum proteomics alongside transcriptomics for comprehensive assessment
  • Ensure reproducibility of findings across different cohorts and platforms

Related Resources & Content

Original Source(s)

Reproducible Molecular Subtypes in Systemic Lupus Erythematosus Are Associated With Disease Activity, Serology, and Distinct Trajectories Over Time

  • by Loqmane Seridi, Eugene Myshkin, Erika Noss, Sheng Gao, Julio Molineros, Carolyn Cuff, Dawn Waterworth, Matthew J. Loza

  • July 1, 2026

Related Content

Side Effects: Bro Science, Actually

Creatine's ATP-buffering trick isn't just for biceps. In mice, it juices up dendritic cells' energy supply, sharpening T-cell priming and shrinking tumors on daily injections. Human DCs got the memo too, at least in a dish. Early days, but a fun plot twist for gym-bag chemistry.

Global research landscape and emerging trends of tertiary lymphoid structures in autoimmune diseases: a bibliometric analysis

The emerging clinical relevance of cell-free DNA in lupus: from mechanistic insights to therapeutic opportunities